Usama Gergis

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Robert J. Soiffer, Haesook T. Kim, Joseph P. McGuirk et al. · Journal of Clinical Oncology · 2017 · 318 citations · Full text

Life Sciences, Hematology, Immunology +16

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

Mohamed A. Kharfan‐Dabaja, Ambuj Kumar, Ernesto Ayala et al. · Transplantation and Cellular Therapy · 2021 · 181 citations · Full text

Medicine, Hematology, Immunology +16

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors

Mohamed Shanavas, Uday Popat, Laura C. Michaelis et al. · Biology of Blood and Marrow Transplantation · 2015 · 142 citations · Full text

Medicine, Hematology, Immunology +13

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML

Joseph M. Scandura, Gail J. Roboz, Michelle Moh et al. · Blood · 2011 · 128 citations · Full text

Medicine, Oncology, Pharmacology +12

Improved survival after acute graft- <i>versus</i> -host disease diagnosis in the modern era

H. Jean Khoury, Tao Wang, Michael Hemmer et al. · Haematologica · 2017 · 109 citations · Full text

Medicine, Hematology, Oncology +13